Literature DB >> 24122390

Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer.

Lauren S Jammallo, Cynthia L Miller, Marybeth Singer, Nora K Horick, Melissa N Skolny, Michelle C Specht, Jean O'Toole, Alphonse G Taghian.   

Abstract

Identifying risk factors for lymphedema in patients treated for breast cancer has become increasingly important, given the current lack of standardization surrounding diagnosis and treatment. Reports on the association of body mass index (BMI) and weight change with lymphedema risk are conflicting. We sought to examine the impact of pre-operative BMI and post-treatment weight change on the incidence of lymphedema. From 2005 to 2011, 787 newly diagnosed breast cancer patients underwent prospective arm volume measurements with a Perometer pre- and post-operatively. BMI was calculated from same-day weight and height measurements. Lymphedema was defined as a relative volume change (RVC) of ≥ 10 %. Univariate and multivariate Cox proportional hazards models were used to evaluate the association between lymphedema risk and pre-operative BMI, weight change, and other demographic and treatment factors. By multivariate analysis, a pre-operative BMI ≥ 30 was significantly associated with an increased risk of lymphedema compared to a pre-operative BMI <25 and 25- <30 (p = 0.001 and p = 0.012, respectively). Patients with a pre-operative BMI 25- <30 were not at an increased risk of lymphedema compared to patients with a pre-operative BMI <25 (p = 0.409). Furthermore, a cumulative absolute weight fluctuation of 10 pounds gained/lost per month post-operatively significantly increased risk of lymphedema (HR: 1.97, p = < 0.0001). In conclusion, pre-operative BMI of ≥ 30 is an independent risk factor for lymphedema, whereas a BMI of 25- <30 is not. Large post-operative weight fluctuations also increase risk of lymphedema. Patients with a pre-operative BMI ≥ 30 and those who experience large weight fluctuations during and after treatment for breast cancer should be considered at higher-risk for lymphedema. Close monitoring or early intervention to ensure optimal treatment of the condition may be appropriate for these patients.

Entities:  

Mesh:

Year:  2013        PMID: 24122390      PMCID: PMC3873728          DOI: 10.1007/s10549-013-2715-7

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  43 in total

1.  Morbidity of sentinel node biopsy in breast cancer: the relationship between the number of excised lymph nodes and lymphedema.

Authors:  Jessica I Goldberg; Lisa I Wiechmann; Elyn R Riedel; Monica Morrow; Kimberly J Van Zee
Journal:  Ann Surg Oncol       Date:  2010-06-24       Impact factor: 5.344

2.  Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study.

Authors:  Rehana L Ahmed; Kathryn H Schmitz; Anna E Prizment; Aaron R Folsom
Journal:  Breast Cancer Res Treat       Date:  2011-07-15       Impact factor: 4.872

Review 3.  Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.

Authors:  Tracey DiSipio; Sheree Rye; Beth Newman; Sandi Hayes
Journal:  Lancet Oncol       Date:  2013-03-27       Impact factor: 41.316

4.  Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months.

Authors:  J M Armer; B R Stewart
Journal:  Lymphology       Date:  2010-09       Impact factor: 1.286

5.  Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology.

Authors:  Marek Ancukiewicz; Cynthia L Miller; Melissa N Skolny; Jean O'Toole; Laura E Warren; Lauren S Jammallo; Michelle C Specht; Alphonse G Taghian
Journal:  Breast Cancer Res Treat       Date:  2012-06-19       Impact factor: 4.872

6.  Immediate breast reconstruction and lymphedema incidence.

Authors:  Melissa A Crosby; Annika Card; Jun Liu; Wayne A Lindstrom; David W Chang
Journal:  Plast Reconstr Surg       Date:  2012-05       Impact factor: 4.730

7.  Standardized method for quantification of developing lymphedema in patients treated for breast cancer.

Authors:  Marek Ancukiewicz; Tara A Russell; Jean Otoole; Michelle Specht; Marybeth Singer; Alexandra Kelada; Colleen D Murphy; Jessica Pogachar; Valeria Gioioso; Megha Patel; Melissa Skolny; Barbara L Smith; Alphonse G Taghian
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-03       Impact factor: 7.038

8.  Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy.

Authors:  W Demark-Wahnefried; B L Peterson; E P Winer; L Marks; N Aziz; P K Marcom; K Blackwell; B K Rimer
Journal:  J Clin Oncol       Date:  2001-05-01       Impact factor: 44.544

9.  Body mass index and breast cancer treatment-related lymphedema.

Authors:  Sheila H Ridner; Mary S Dietrich; Bob R Stewart; Jane M Armer
Journal:  Support Care Cancer       Date:  2011-01-16       Impact factor: 3.603

10.  Breast cancer-related lymphedema--what are the significant predictors and how they affect the severity of lymphedema?

Authors:  Atilla Soran; Gina D'Angelo; Mirsada Begovic; Figen Ardic; Ali Harlak; H Samuel Wieand; Victor G Vogel; Ronald R Johnson
Journal:  Breast J       Date:  2006 Nov-Dec       Impact factor: 2.431

View more
  29 in total

1.  Hand Edema in Patients at Risk of Breast Cancer-Related Lymphedema: Health Professionals Should Take Notice.

Authors:  Cheryl L Brunelle; Meyha N Swaroop; Melissa N Skolny; Maria S Asdourian; Hoda E Sayegh; Alphonse G Taghian
Journal:  Phys Ther       Date:  2018-06-01

Review 2.  Breast Cancer-Related Lymphedema: Risk Factors, Screening, Management, and the Impact of Locoregional Treatment.

Authors:  Sarah A McLaughlin; Cheryl L Brunelle; Alphonse Taghian
Journal:  J Clin Oncol       Date:  2020-05-22       Impact factor: 44.544

3.  Lymphedema Signs, Symptoms, and Diagnosis in Women Who Are in Minority and Low-Income Groups and Have Survived Breast Cancer.

Authors:  Ann Marie Flores; Jason Nelson; Lee Sowles; Rebecca G Stephenson; Kathryn Robinson; Andrea Cheville; Antoinette P Sander; William J Blot
Journal:  Phys Ther       Date:  2020-03-10

Review 4.  Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments.

Authors:  Tessa C Gillespie; Hoda E Sayegh; Cheryl L Brunelle; Kayla M Daniell; Alphonse G Taghian
Journal:  Gland Surg       Date:  2018-08

Review 5.  Use of technology to facilitate a prospective surveillance program for breast cancer-related lymphedema at the Massachusetts General Hospital.

Authors:  Lauren M Havens; Cheryl L Brunelle; Tessa C Gillespie; Madison Bernstein; Loryn K Bucci; Yara W Kassamani; Alphonse G Taghian
Journal:  Mhealth       Date:  2021-01-20

6.  Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study.

Authors:  Marilyn L Kwan; Song Yao; Valerie S Lee; Janise M Roh; Qianqian Zhu; Isaac J Ergas; Qian Liu; Yali Zhang; Susan E Kutner; Charles P Quesenberry; Christine B Ambrosone; Lawrence H Kushi
Journal:  Breast Cancer Res Treat       Date:  2016-07-22       Impact factor: 4.872

7.  Impact of Ipsilateral Blood Draws, Injections, Blood Pressure Measurements, and Air Travel on the Risk of Lymphedema for Patients Treated for Breast Cancer.

Authors:  Chantal M Ferguson; Meyha N Swaroop; Nora Horick; Melissa N Skolny; Cynthia L Miller; Lauren S Jammallo; Cheryl Brunelle; Jean A O'Toole; Laura Salama; Michelle C Specht; Alphonse G Taghian
Journal:  J Clin Oncol       Date:  2015-12-07       Impact factor: 44.544

8.  Diagnostic Methods, Risk Factors, Prevention, and Management of Breast Cancer-Related Lymphedema: Past, Present, and Future Directions.

Authors:  Hoda E Sayegh; Maria S Asdourian; Meyha N Swaroop; Cheryl L Brunelle; Melissa N Skolny; Laura Salama; Alphonse G Taghian
Journal:  Curr Breast Cancer Rep       Date:  2017-05-03

9.  Prevalence of Subclinical Systemic Lymphedema in Patients Following Treatment for Breast Cancer and Association with Body Mass Index.

Authors:  Jose Maria Pereira de Godoy; Lívia Maria Pereira de Godoy; Maria de Fatima Guerreiro Godoy
Journal:  Cureus       Date:  2020-03-16

10.  Association Between Precautionary Behaviors and Breast Cancer-Related Lymphedema in Patients Undergoing Bilateral Surgery.

Authors:  Maria S Asdourian; Meyha N Swaroop; Hoda E Sayegh; Cheryl L Brunelle; Amir I Mina; Hui Zheng; Melissa N Skolny; Alphonse G Taghian
Journal:  J Clin Oncol       Date:  2017-10-04       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.